Top Markets
#1 Cortex Cortex +34.29%
#2 Seeker Seeker +17.21%
#3 Official Trump Official Trump +10.59%
#4 peaq peaq +9.63%
#5 EXOD EXOD +9.04%
#6 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +8.12%
#7 Ethena Staked ENA Ethena Staked ENA +6.55%
#8 TDCCP TDCCP +6.19%
#9 Stacks Stacks +4.96%
#10 aelf aelf +4.84%
Coin of the day
Cortex Cortex
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Damora Therapeutics, Inc. Damora Therapeutics, Inc.

Damora Therapeutics, Inc.

DMRA
Classifica tra le azioni #6696
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering... Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye, its corporate operations are based in Boston, Massachusetts.
Prezzo delle azioni
$30.90
Ultima sincronizzazione: 2026-08-27
Capitalizzazione di mercato
$1.90B
Variazione (1 giorno)
1.68%
Variazione (1 anno)
859.63%
Paese
US
Scambia Damora Therapeutics, Inc. (DMRA)

Categoria

Healthcare
Storico del rendimento da dividendi per Damora Therapeutics, Inc. (DMRA)
Il rendimento da dividendi (TTM) di Damora Therapeutics, Inc. (simbolo azionario: DMRA) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Damora Therapeutics, Inc. (DMRA) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH